Literature DB >> 33559191

Fine-Feature Modifications to Strained Ruthenium Complexes Radically Alter Their Hypoxic Anticancer Activity.

Houston D Cole1, John A Roque1,2, Liubov M Lifshits1, Rachel Hodges2, Patrick C Barrett2, Dmytro Havrylyuk3, David Heidary3, Elamparuthi Ramasamy1, Colin G Cameron1, Edith C Glazer3, Sherri A McFarland1.   

Abstract

In an earlier study of π-expansive ruthenium complexes for photodynamic and photochemo-therapies, it was shown that a pair of structural isomers differing only in the connection point of a naphthalene residue exhibited vastly different biological activity. These isomers are further explored in this paper through the activity of their functionalized derivatives. In normoxia, the inactive 2-NIP isomer (5) can be made as photocytotoxic as the active 1-NIP isomer (1) by functionalizing with methyl or methoxy groups, while methoxy variants of the 1-NIP isomer became inactive. In all cases, the singlet oxygen sensitization quantum yield was below 1%. Hypoxic photocytotoxicity was attenuated, with only three of the series showing any activity, notwithstanding the photodissociative ligands. The results here are consistent with the earlier findings in that seemingly minor structural modifications on the non-strained ligand can dramatically modulate the normoxic and hypoxic activity of these strained compounds and that these changes appear to exert a greater influence on photocytotoxicity than singlet oxygen sensitization or rates of photosubstitution in cell-free conditions would suggest.
© 2021 American Society for Photobiology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33559191      PMCID: PMC8349932          DOI: 10.1111/php.13395

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.521


  50 in total

1.  Illuminating cytochrome P450 binding: Ru(ii)-caged inhibitors of CYP17A1.

Authors:  Ao Li; Rahul Yadav; Jessica K White; Mackenzie K Herroon; Brian P Callahan; Izabela Podgorski; Claudia Turro; Emily E Scott; Jeremy J Kodanko
Journal:  Chem Commun (Camb)       Date:  2017-03-28       Impact factor: 6.222

2.  Os(II) Oligothienyl Complexes as a Hypoxia-Active Photosensitizer Class for Photodynamic Therapy.

Authors:  John A Roque; Patrick C Barrett; Houston D Cole; Liubov M Lifshits; Evan Bradner; Ge Shi; David von Dohlen; Susy Kim; Nino Russo; Gagan Deep; Colin G Cameron; Marta E Alberto; Sherri A McFarland
Journal:  Inorg Chem       Date:  2020-10-30       Impact factor: 5.165

3.  A new strategy for neurochemical photodelivery: metal-ligand heterolytic cleavage.

Authors:  Leonardo Zayat; Cecilia Calero; Pablo Alborés; Luis Baraldo; Roberto Etchenique
Journal:  J Am Chem Soc       Date:  2003-01-29       Impact factor: 15.419

4.  Dual-Action Ru(II) Complexes with Bulky π-Expansive Ligands: Phototoxicity without DNA Intercalation.

Authors:  Nicholas P Toupin; Sandeep Nadella; Sean J Steinke; Claudia Turro; Jeremy J Kodanko
Journal:  Inorg Chem       Date:  2020-02-25       Impact factor: 5.165

5.  Light-activated ruthenium complexes photobind DNA and are cytotoxic in the photodynamic therapy window.

Authors:  Erin Wachter; David K Heidary; Brock S Howerton; Sean Parkin; Edith C Glazer
Journal:  Chem Commun (Camb)       Date:  2012-10-07       Impact factor: 6.222

6.  Ruthenium polypyridyl phototriggers: from beginnings to perspectives.

Authors:  Leonardo Zayat; Oscar Filevich; Luis M Baraldo; Roberto Etchenique
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2013-06-17       Impact factor: 4.226

7.  Ruthenium(II) bipyridyl complexes as photolabile caging groups for amines.

Authors:  Leonardo Zayat; Marcelo Salierno; Roberto Etchenique
Journal:  Inorg Chem       Date:  2006-02-20       Impact factor: 5.165

8.  Photo-Uncaging of a Microtubule-Targeted Rigidin Analogue in Hypoxic Cancer Cells and in a Xenograft Mouse Model.

Authors:  Vincent H S van Rixel; Vadde Ramu; Austin B Auyeung; Nataliia Beztsinna; David Y Leger; Lucien N Lameijer; Stan T Hilt; Sylvia E Le Dévédec; Tugba Yildiz; Tania Betancourt; M Brenton Gildner; Todd W Hudnall; Vincent Sol; Bertrand Liagre; Alexander Kornienko; Sylvestre Bonnet
Journal:  J Am Chem Soc       Date:  2019-11-06       Impact factor: 15.419

9.  Breaking the barrier: an osmium photosensitizer with unprecedented hypoxic phototoxicity for real world photodynamic therapy.

Authors:  John A Roque; Patrick C Barrett; Houston D Cole; Liubov M Lifshits; Ge Shi; Susan Monro; David von Dohlen; Susy Kim; Nino Russo; Gagan Deep; Colin G Cameron; Marta E Alberto; Sherri A McFarland
Journal:  Chem Sci       Date:  2020-08-03       Impact factor: 9.825

10.  The Self-Assembly of a Cyclometalated Palladium Photosensitizer into Protein-Stabilized Nanorods Triggers Drug Uptake In Vitro and In Vivo.

Authors:  Xue-Quan Zhou; Ming Xiao; Vadde Ramu; Jonathan Hilgendorf; Xuezhao Li; Panagiota Papadopoulou; Maxime A Siegler; Alexander Kros; Wen Sun; Sylvestre Bonnet
Journal:  J Am Chem Soc       Date:  2020-05-27       Impact factor: 15.419

View more
  6 in total

1.  Ruthenium Photosensitizers for NIR PDT Require Lowest-Lying Triplet Intraligand (3IL) Excited States.

Authors:  Liubov M Lifshits; John A Roque; Elamparuthi Ramasamy; Randolph P Thummel; Colin G Cameron; Sherri A McFarland
Journal:  J Photochem Photobiol       Date:  2021-09-15

2.  Insights into enantioselective separations of ionic metal complexes by sub/supercritical fluid chromatography.

Authors:  Troy T Handlovic; M Farooq Wahab; Houston D Cole; Nagham Alatrash; Elamparuthi Ramasamy; Frederick M MacDonnell; Sherri A McFarland; Daniel W Armstrong
Journal:  Anal Chim Acta       Date:  2022-07-18       Impact factor: 6.911

3.  DNA Interaction, DNA Photocleavage, Photocytotoxicity In Vitro, and Molecular Docking of Naphthyl-Appended Ruthenium Complexes.

Authors:  Xia Hu; Qian Luo; Yao Qin; Yao Wu; Xue-Wen Liu
Journal:  Molecules       Date:  2022-06-08       Impact factor: 4.927

4.  Metalloimmunotherapy with Rhodium and Ruthenium Complexes: Targeting Tumor-Associated Macrophages.

Authors:  Nicholas Toupin; Mackenzie K Herroon; Randolph P Thummel; Claudia Turro; Izabela Podgorski; Heather Gibson; Jeremy J Kodanko
Journal:  Chemistry       Date:  2022-03-24       Impact factor: 5.020

5.  Anticancer Agent with Inexplicable Potency in Extreme Hypoxia: Characterizing a Light-Triggered Ruthenium Ubertoxin.

Authors:  Houston D Cole; John A Roque; Ge Shi; Liubov M Lifshits; Elamparuthi Ramasamy; Patrick C Barrett; Rachel O Hodges; Colin G Cameron; Sherri A McFarland
Journal:  J Am Chem Soc       Date:  2021-12-09       Impact factor: 16.383

6.  Intraligand Excited States Turn a Ruthenium Oligothiophene Complex into a Light-Triggered Ubertoxin with Anticancer Effects in Extreme Hypoxia.

Authors:  John A Roque Iii; Houston D Cole; Patrick C Barrett; Liubov M Lifshits; Rachel O Hodges; Susy Kim; Gagan Deep; Antonio Francés-Monerris; Marta E Alberto; Colin G Cameron; Sherri A McFarland
Journal:  J Am Chem Soc       Date:  2022-04-28       Impact factor: 16.383

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.